List out five drugs and five enzymes for competitive inhibitor found in a local medical shops.
Here's a quick answer based on my existing knowledge while I search for more detail:
Competitive inhibitors block an enzyme's active site by resembling the substrate. Many common drugs work this way - statins inhibit HMG-CoA reductase, ACE inhibitors block angiotensin-converting enzyme, and methotrexate inhibits dihydrofolate reductase.
Searching sources...
Reading File
Finding Sources
Searching the Web
common drugs competitive enzyme inhibitors available pharmacy examples mechanisms
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
I now have solid textbook-confirmed data. Let me compile the full, well-sourced answer.
Competitive Enzyme Inhibitors: 5 Drugs & 5 Enzymes Available at Local Pharmacies
Competitive inhibitors bind to the active site of an enzyme (mimicking the natural substrate), blocking substrate access. This increases the apparent Km while leaving Vmax unchanged - and the inhibition can be reversed by increasing substrate concentration.
5 Drugs That Act as Competitive Inhibitors
| # | Drug | Enzyme Inhibited | Clinical Use | Available As |
|---|---|---|---|---|
| 1 | Atorvastatin / Rosuvastatin (Statins) | HMG-CoA reductase | Lowers cholesterol | Lipitor, Crestor tablets |
| 2 | Enalapril / Lisinopril (ACE Inhibitors) | Angiotensin-converting enzyme (ACE) | Hypertension, heart failure | Envas, Lisinace tablets |
| 3 | Methotrexate | Dihydrofolate reductase (DHFR) | Cancer, rheumatoid arthritis, psoriasis | MTX tablets / injection |
| 4 | Ibuprofen / Naproxen (NSAIDs) | Cyclooxygenase (COX-1 and COX-2) | Pain, inflammation, fever | Brufen, Naprosyn tablets |
| 5 | Sildenafil (Viagra) | Phosphodiesterase-5 (PDE-5) | Erectile dysfunction, pulmonary arterial hypertension | Penegra, Suhagra tablets |
5 Enzymes Targeted by These Competitive Inhibitors
| # | Enzyme | Drug Inhibitor | Normal Substrate | Biological Role |
|---|---|---|---|---|
| 1 | HMG-CoA Reductase | Statins (atorvastatin, pravastatin) | HMG-CoA | Rate-limiting step in cholesterol biosynthesis |
| 2 | Angiotensin-Converting Enzyme (ACE) | ACE inhibitors (enalapril, lisinopril) | Angiotensin I | Converts Ang I → Ang II (raises blood pressure) |
| 3 | Dihydrofolate Reductase (DHFR) | Methotrexate | Dihydrofolate | Reduces dihydrofolate to tetrahydrofolate (needed for DNA synthesis) |
| 4 | Cyclooxygenase (COX-1 / COX-2) | NSAIDs (ibuprofen, naproxen) | Arachidonic acid | Synthesizes prostaglandins (mediators of pain and inflammation) |
| 5 | Phosphodiesterase-5 (PDE-5) | Sildenafil, tadalafil | cGMP | Breaks down cGMP in vascular smooth muscle (controls vasodilation) |
Key Pharmacology Points
- Statins are the textbook example of competitive inhibition - they are structural analogs of HMG-CoA and compete directly for the active site of HMG-CoA reductase. - Biochemistry, Lippincott Illustrated Reviews, 8th Ed, p. 189
- Methotrexate competitively inhibits DHFR and is so potent that resistance sometimes develops through gene amplification (upregulating the enzyme itself). - Goodman & Gilman's Pharmacological Basis of Therapeutics
- ACE inhibitors are cited in clinical biochemistry as a classic example of drugs acting as competitive inhibitors of a targeted enzyme. - Henry's Clinical Diagnosis and Management by Laboratory Methods
- NSAIDs like ibuprofen and naproxen are reversible competitive/mixed inhibitors of COX enzymes (unlike aspirin, which is irreversible).
- Sildenafil mimics cGMP structurally, competitively occupying PDE-5's active site, preventing cGMP breakdown and sustaining vasodilation.
Note on local availability: All five drugs above are widely stocked in pharmacies across India and most countries. Statins, ACE inhibitors, and NSAIDs are available over-the-counter or by prescription; methotrexate and sildenafil require a prescription.
Give 2 more
Here are 2 more drug + enzyme pairs for competitive inhibition, confirmed from medical textbooks:
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Here are 2 more drug + enzyme pairs, both confirmed from medical textbooks and commonly available at pharmacies:
2 Additional Competitive Inhibitor Drugs
6. Allopurinol - Xanthine Oxidase
| Feature | Detail |
|---|---|
| Drug | Allopurinol (brand names: Zyloric, Uricad) |
| Enzyme Inhibited | Xanthine Oxidase |
| Normal Substrate | Xanthine and hypoxanthine |
| Mechanism | Allopurinol is a purine analogue - it structurally mimics hypoxanthine and competitively occupies the active site of xanthine oxidase, blocking the conversion of xanthine/hypoxanthine to uric acid. This lowers plasma urate levels. |
| Clinical Use | Gout, hyperuricemia, uric acid kidney stones |
| Availability | Widely available as 100 mg and 300 mg tablets at any pharmacy |
- Katzung's Basic and Clinical Pharmacology, 16th Ed confirms allopurinol is a purine analogue that inhibits xanthine oxidase, causing a fall in plasma urate.
7. Carbidopa - DOPA Decarboxylase (Aromatic L-amino acid decarboxylase)
| Feature | Detail |
|---|---|
| Drug | Carbidopa (given combined with levodopa - Syndopa, Sinemet) |
| Enzyme Inhibited | DOPA decarboxylase (Aromatic L-amino acid decarboxylase) |
| Normal Substrate | L-DOPA |
| Mechanism | Carbidopa structurally resembles L-DOPA and competitively inhibits DOPA decarboxylase in the peripheral tissues, preventing conversion of levodopa to dopamine before it crosses the blood-brain barrier. This allows more levodopa to reach the brain. |
| Clinical Use | Parkinson's disease (always used with levodopa) |
| Availability | Available as combined Levodopa + Carbidopa tablets (Syndopa 110, Syndopa 275) at pharmacies |
Updated Summary Table (All 7)
| # | Drug | Enzyme | Use |
|---|---|---|---|
| 1 | Atorvastatin / Rosuvastatin | HMG-CoA Reductase | Cholesterol lowering |
| 2 | Enalapril / Lisinopril | ACE | Hypertension |
| 3 | Methotrexate | Dihydrofolate Reductase (DHFR) | Cancer / Arthritis |
| 4 | Ibuprofen / Naproxen | Cyclooxygenase (COX) | Pain / Inflammation |
| 5 | Sildenafil | Phosphodiesterase-5 (PDE-5) | Erectile dysfunction |
| 6 | Allopurinol | Xanthine Oxidase | Gout |
| 7 | Carbidopa | DOPA Decarboxylase | Parkinson's disease |
List out five drugs and five enzymes for non competitive inhibitor found in a local medical shops.
Non-competitive inhibitors bind to an allosteric site (not the active site), changing enzyme shape and reducing activity regardless of substrate concentration. This lowers Vmax while Km stays the same. Examples include some antibiotics, antifungals, and CNS drugs.
Searching sources...
Finding Sources
Searching the Web
drugs acting as noncompetitive enzyme inhibitors pharmacy examples mechanisms
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
I now have enough from the textbooks. Here is the full, well-sourced answer:
Non-Competitive Enzyme Inhibitors: 5 Drugs & 5 Enzymes Available at Local Pharmacies
A non-competitive inhibitor binds to an allosteric site (separate from the active site) on the enzyme - or on the enzyme-substrate complex. This causes a conformational change that reduces catalytic activity. The key kinetic signature: Vmax decreases, Km stays unchanged. Increasing substrate concentration cannot overcome the inhibition.
5 Drugs That Act as Non-Competitive Inhibitors
| # | Drug | Enzyme Inhibited | Clinical Use | Available As |
|---|---|---|---|---|
| 1 | Aspirin | Cyclooxygenase (COX-1 / COX-2) | Pain, fever, antiplatelet | Ecosprin, Disprin tablets |
| 2 | Omeprazole / Pantoprazole (PPIs) | H⁺/K⁺-ATPase (Proton Pump) | Acid peptic disease, GERD, ulcers | Omez, Pan tablets |
| 3 | Donepezil | Acetylcholinesterase (AChE) | Alzheimer's disease | Donep, Aricept tablets |
| 4 | Theophylline | Phosphodiesterase (PDE) | Asthma, COPD | Theodur, Deriphyllin tablets |
| 5 | Metronidazole | Aldehyde dehydrogenase / Ferredoxin-linked enzymes | Anaerobic infections, H. pylori, amoebiasis | Flagyl, Metrogyl tablets |
5 Enzymes Targeted by These Non-Competitive Inhibitors
| # | Enzyme | Drug Inhibitor | Normal Function | Inhibition Effect |
|---|---|---|---|---|
| 1 | Cyclooxygenase (COX-1 / COX-2) | Aspirin | Converts arachidonic acid to prostaglandins and thromboxane | Aspirin irreversibly acetylates a serine residue outside the active site channel - a classic non-competitive irreversible inhibitor. Permanently inactivates the enzyme. |
| 2 | H⁺/K⁺-ATPase (Proton Pump) | Omeprazole, Pantoprazole | Pumps H⁺ ions into the gastric lumen to produce stomach acid | PPIs are prodrugs activated in the acidic canaliculi - they covalently and irreversibly bind the pump's cysteine residues (allosteric to the ion pathway), permanently blocking acid secretion. |
| 3 | Acetylcholinesterase (AChE) | Donepezil | Breaks down acetylcholine at the synaptic cleft | Donepezil is a reversible non-competitive inhibitor - it binds the peripheral anionic site of AChE (distinct from the catalytic site), slowing ACh hydrolysis and boosting cholinergic transmission in Alzheimer's. |
| 4 | Phosphodiesterase (PDE) | Theophylline | Breaks down cAMP and cGMP in smooth muscle and inflammatory cells | Theophylline non-competitively inhibits PDE, preventing cAMP breakdown. Elevated cAMP causes bronchial smooth muscle relaxation and has anti-inflammatory effects. |
| 5 | Ferredoxin oxidoreductase / Aldehyde dehydrogenase | Metronidazole | Electron transfer in anaerobic metabolism | Metronidazole's reduced nitroso intermediates bind to allosteric/non-active-site regions of key anaerobic enzymes, disrupting DNA and electron transport in anaerobes and protozoa. |
Key Comparison: Competitive vs. Non-Competitive Inhibition
| Feature | Competitive | Non-Competitive |
|---|---|---|
| Binding site | Active site | Allosteric site |
| Effect on Km | Increases | No change |
| Effect on Vmax | No change | Decreases |
| Overcome by adding substrate? | Yes | No |
| Example drug | Atorvastatin | Aspirin |
Important Notes
- Aspirin is the most clinically important non-competitive (irreversible) inhibitor in everyday medicine. It acetylates COX permanently - this is why its antiplatelet effect lasts the entire platelet lifespan (~7-10 days) even after the drug is cleared. Confirmed by Goodman & Gilman's Pharmacological Basis of Therapeutics: "Aspirin is a noncompetitive, irreversible inhibitor because it acetylates the isozymes in the hydrophobic AA-binding channel."
- PPIs (omeprazole, pantoprazole) irreversibly block H⁺/K⁺-ATPase. Confirmed by Katzung's Basic and Clinical Pharmacology, 16th Ed: "Irreversible blockade of H⁺/K⁺-ATPase pump in active parietal cells of stomach."
- Donepezil is confirmed as a "noncompetitive, reversible acetylcholinesterase inhibitor" by Kaplan & Sadock's Comprehensive Textbook of Psychiatry.
- All five drugs are routinely stocked at pharmacies - aspirin, omeprazole, and theophylline are available over the counter; donepezil and metronidazole require a prescription.
Create a comparison poster of competitive vs non-competitive inhibitors with examples
Creating a detailed comparison poster now!
Generating Image
A professional medical/biochemistry educational poster comparing Competitive vs Non-Competitive Enzyme Inhibitors. Layout: Two-column design with a clear header at top reading "Enzyme Inhibition: Competitive vs Non-Competitive". LEFT COLUMN (blue theme) titled "COMPETITIVE INHIBITION": - Diagram showing inhibitor blocking the active site of an enzyme - Key features listed: "Binds Active Site", "Km INCREASES", "Vmax UNCHANGED", "Overcome by excess substrate" - Lineweaver-Burk plot sketch showing lines intersecting on Y-axis - Drug examples in a box: 1. Atorvastatin → HMG-CoA Reductase, 2. Enalapril → ACE, 3. Methotrexate → DHFR, 4. Sildenafil → PDE-5, 5. Allopurinol → Xanthine Oxidase RIGHT COLUMN (red/orange theme) titled "NON-COMPETITIVE INHIBITION": - Diagram showing inhibitor binding an allosteric site away from active site - Key features listed: "Binds Allosteric Site", "Km UNCHANGED", "Vmax DECREASES", "Cannot be overcome by substrate" - Lineweaver-Burk plot sketch showing lines intersecting on X-axis - Drug examples in a box: 1. Aspirin → COX-1/COX-2, 2. Omeprazole → H+/K+-ATPase, 3. Donepezil → AChE, 4. Theophylline → Phosphodiesterase, 5. Metronidazole → Ferredoxin Oxidoreductase CENTER divider with a comparison table showing Km and Vmax changes side by side. Footer: Clean, academic style with white background.
!
404 Not Found. {'message': '{\n "error": {\n "code": 404,\n "message": "Publisher model `projects/engaged-beaker-474810-u2/locations/global/publishers/google/models/gemini-3-pro-image-preview` was not found or your project does not have access to it. Ensure you are using a valid model name and that the model is available in the specified region. For more information, see: https://docs.cloud.google.com/gemini-enterprise-agent-platform/resources/locations.",\n "status": "NOT_FOUND"\n }\n}\n', 'status': 'Not Found'}
We encountered an error while processing your request. Please try again or reach out to us for help.
Give 1 more
Since the last topic was non-competitive inhibitors, I'll add 1 more drug + enzyme pair for that category.
Searching sources...
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Here is the 6th non-competitive inhibitor drug, confirmed from multiple medical textbooks:
6. Disulfiram - Aldehyde Dehydrogenase
| Feature | Detail |
|---|---|
| Drug | Disulfiram (brand names: Antabuse, Esperal) |
| Enzyme Inhibited | Aldehyde Dehydrogenase (ALDH) |
| Normal Substrate | Acetaldehyde |
| Type of Inhibition | Irreversible non-competitive inhibition - binds covalently to enzyme sites away from the catalytic center |
| Mechanism | Ethanol is normally metabolized in two steps: Ethanol → Acetaldehyde (by alcohol dehydrogenase) → Acetyl-CoA (by aldehyde dehydrogenase). Disulfiram irreversibly inhibits aldehyde dehydrogenase, causing toxic acetaldehyde to accumulate in the blood. This triggers a highly unpleasant reaction: flushing, nausea, vomiting, palpitations, and headache - making alcohol consumption aversive. |
| Clinical Use | Alcohol use disorder (aversion therapy) |
| Availability | Available by prescription at pharmacies (Antabuse 250 mg tablets) |
- Confirmed by Stahl's Essential Psychopharmacology: "It is an irreversible inhibitor of the liver enzyme aldehyde dehydrogenase that normally metabolizes alcohol."
- Confirmed by Kaplan & Sadock's Synopsis of Psychiatry: "Disulfiram is an aldehyde dehydrogenase inhibitor that interferes with the metabolism of alcohol by producing a marked increase in blood acetaldehyde concentration."
Updated Non-Competitive Inhibitors List (All 6)
| # | Drug | Enzyme | Use |
|---|---|---|---|
| 1 | Aspirin | COX-1 / COX-2 | Pain, antiplatelet |
| 2 | Omeprazole / Pantoprazole | H⁺/K⁺-ATPase | Acid peptic disease |
| 3 | Donepezil | Acetylcholinesterase (AChE) | Alzheimer's disease |
| 4 | Theophylline | Phosphodiesterase (PDE) | Asthma, COPD |
| 5 | Metronidazole | Ferredoxin Oxidoreductase | Anaerobic infections |
| 6 | Disulfiram | Aldehyde Dehydrogenase | Alcohol use disorder |
List out five drugs and five enzymes for un competitive inhibitor found in a local medical shops.
Uncompetitive inhibitors bind only to the enzyme-substrate (ES) complex - not to the free enzyme. This lowers both Vmax and Km equally, so their ratio (Vmax/Km) stays constant. It's the rarest inhibition type clinically.
Searching sources...
Finding Sources
Searching the Web
drugs uncompetitive enzyme inhibitors clinical examples pharmacy metformin lithium
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching the Web
uncompetitive enzyme inhibitors drugs clinical examples lithium acarbose APAD
I now have sufficient data from multiple sources. Here is the complete, well-sourced answer:
Uncompetitive Enzyme Inhibitors: 5 Drugs & 5 Enzymes Available at Local Pharmacies
An uncompetitive inhibitor binds only to the enzyme-substrate (ES) complex - it cannot bind the free enzyme. This traps the ES complex in an inactive form. The kinetic result is that both Vmax AND Km decrease by the same ratio, producing parallel lines on a Lineweaver-Burk plot (unlike the other two types). Importantly, adding more substrate makes inhibition worse - the opposite of competitive inhibition.
5 Drugs That Act as Uncompetitive Inhibitors
| # | Drug | Enzyme Inhibited | Clinical Use | Available As |
|---|---|---|---|---|
| 1 | Acarbose | α-Glucosidase | Type 2 diabetes (reduces post-meal glucose spike) | Glucobay, Acarbose tablets |
| 2 | Lithium Carbonate | Inositol Monophosphatase (IMPase) | Bipolar disorder | Lithosun, Licab tablets |
| 3 | Nevirapine (NNRTI) | HIV Reverse Transcriptase | HIV/AIDS | Nevimune, Nevirex tablets |
| 4 | Methotrexate (at high dose) | Thymidylate Synthase (TS) | Cancer, severe psoriasis, rheumatoid arthritis | MTX tablets / injection |
| 5 | Chloroquine | Heme Polymerase (Hemozoin synthase) | Malaria | Lariago, Chloroquine tablets |
5 Enzymes Targeted by These Uncompetitive Inhibitors
| # | Enzyme | Drug | Normal Function | Effect of Uncompetitive Inhibition |
|---|---|---|---|---|
| 1 | α-Glucosidase | Acarbose | Breaks down complex carbohydrates (oligosaccharides) into simple sugars in the small intestine | Acarbose binds the ES complex in the intestinal brush border, slowing carbohydrate digestion - prevents post-meal blood glucose spikes |
| 2 | Inositol Monophosphatase (IMPase) | Lithium | Recycles inositol from inositol-1-phosphate in the phosphatidylinositol signaling pathway | Lithium binds only after substrate (inositol-1-phosphate) is bound, depleting free inositol and dampening excessive neuronal signaling in mania |
| 3 | HIV Reverse Transcriptase (RT) | Nevirapine (NNRTIs) | Converts viral RNA into DNA (essential for HIV replication) | NNRTIs bind the ES complex (RT + nucleotide substrate), allosterically distorting the catalytic site - blocks viral DNA synthesis |
| 4 | Thymidylate Synthase (TS) | Methotrexate (via FdUMP) | Converts dUMP to dTMP (required for DNA synthesis) | Methotrexate's metabolite FdUMP forms a stable ternary complex with TS and its substrate (forms ES-inhibitor complex), blocking thymidylate production and halting cancer cell DNA synthesis |
| 5 | Heme Polymerase (Hemozoin Synthase) | Chloroquine | Converts toxic free heme into non-toxic hemozoin crystal inside the malaria parasite | Chloroquine accumulates inside the parasite's food vacuole and binds the growing heme-enzyme complex, blocking hemozoin formation and causing toxic heme accumulation that kills the parasite |
Kinetic Signature of Uncompetitive Inhibition
| Feature | Uncompetitive | Competitive | Non-Competitive |
|---|---|---|---|
| Binds | ES complex only | Free enzyme (active site) | Free enzyme (allosteric site) |
| Km | Decreases | Increases | Unchanged |
| Vmax | Decreases | Unchanged | Decreases |
| Lineweaver-Burk plot | Parallel lines | Same Y-intercept | Same X-intercept |
| Overcome by more substrate? | No - gets worse | Yes | No |
Important Clinical Note
Uncompetitive inhibition is relatively rare in clinical pharmacology compared to competitive inhibition. Many drugs listed above are technically mixed inhibitors with a strong uncompetitive component, or act uncompetitively under specific substrate concentrations. The clearest textbook examples are lithium → IMPase and NNRTIs → reverse transcriptase, both widely cited in biochemistry and pharmacology literature. - Assessment of Enzyme Inhibition, PMC6152246; MedCrave Pharmacotherapy Review
All five drugs are available at pharmacies - acarbose and chloroquine are relatively accessible; lithium, nevirapine, and methotrexate require prescriptions.
This is a shared conversation. Sign in to Orris to start your own chat.